Group P exhibited the highest increase in body weight, while other treatment groups also showed a positive trend in body weight gain, though they were not statistically significant.
← all excerpts
Multiple Benefits of Empagliflozin in PCOS: Evidence from a Preclinical Rat Model.
2
—
—
The sentences
However, in a study on systolic blood pressure, the EMPA-treated group did not reach statistical significance compared to the non- treated PCOS group.